.png){kind=icon}
返回
PMAP: databases for analyzing proteolytic events and pathways
.png){kind=icon}
OA
AI
DOI：10.1093/nar/gkn683.png)
.png){kind=icon}
.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
The Proteolysis MAP (PMAP, http://www.proteolysis.org) is a user-friendly website intended to aid the scientific community in reasoning about proteolytic networks and pathways. PMAP is comprised of five databases, linked together in one environment. The foundation databases, Protease-DB and SubstrateDB, are driven by an automated annotation pipeline that generates dynamic 'Molecule Pages', rich in molecular information. PMAP also contains two community annotated databases focused on function; CutDB has information on more than 5000 proteolytic events, and ProfileDB is dedicated to information of the substrate recognition specificity of proteases. Together, the content within these four databases will ultimately feed PathwayDB, which will be comprised of known pathways whose function can be dynamically modeled in a rule-based manner, and hypothetical pathways suggested by semi-automated culling of the literature. A Protease Toolkit is also available for the analysis of proteases and proteolysis. Here, we describe how the databases of PMAP can be used to foster understanding of proteolytic pathways, and equally as significant, to reason about proteolysis.
Keyword:
DISEASE
PREDICTION
SOFTWARE
UNIPROT
BIOLOGY
CELL
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
13.1
论文数:
3.6W
被引数:
29.0W
机构
引用论文
.png){kind=icon}
分享收藏分享收藏Development and Validation of a Scale Assessing Spiritual Needs for Korean Patients with Cancer评估韩国癌症患者精神需求的量表的开发和验证
PREAI
分享收藏Evidence for a cytoplasmic pathway of oxalate biosynthesis in Aspergillus niger黑曲霉中草酸盐生物合成的细胞质途径的证据
OAAI
OAAI分享收藏Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group.在社区肿瘤学实践中，使用epoetin alfa治疗对癌症化疗期间非骨髓性恶性肿瘤患者临床结局的影响。Procrit研究小组。
PREAI
分享收藏
查看更多内容